Document:

Exhibit 10.14

    
      

    

    Exhibit
      10.14

     

     

    

    CONSULTING
      AGREEMENT

    

    THIS
      AGREEMENT, made as of January 17, 2004, between EYE
      CARE INTERNATIONAL, INC.,
      a
      Delaware corporation with offices located at 1511 N. Westshore Boulevard, Suite
      925, Tampa, Florida 33607 (hereinafter referred to as the “Company”), and Jana
      Corporation, whose address is 770 SE 19th
      Avenue,
      Suite 1, Deerfield Beach, FL 33441, (hereinafter referred to as
“Consultant”).

    W
      I T N E S S E T H

    WHEREAS,
      the
      Company is desirous of entering into an agreement with Consultant that will
      assure the Company of services of Consultant for an extended period of time;
      and

    WHEREAS,
      Consultant is willing to enter into such an agreement.

    NOW,
      THEREFORE,
      intending to be legally bound hereby, it is agreed by and between the parties
      hereto as follows:

    1.         
      Term
      and Duties:

    (a)         
      The
      Company agrees to retain the services of Consultant, and Consultant agrees
      to
      provide services as Consultant, in accordance with the terms of this Agreement.
      The term of this Agreement shall be for yearly periods commencing on the date
      hereof and continuing for a yearly period thereafter, unless terminated by
      either party hereto upon thirty (30) days written notice.

    (b)         
      During
      the term as stated above, Consultant shall provide such services to the Company,
      as may be requested by the Company; shall cooperate with the management of
      the
      Company in the advancement of the Company’s best interests and report directly
      and be responsible 

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    to
      the
      Chief Executive Officer (CEO) of the Company. Consultant shall faithfully
      perform the duties, within his fields of expertise, including, without
      limitation, advice in connection with development and expansion of the Company’s
      sales and marketing program and merger and acquisition targets and market public
      relations and strategies. In consideration for Consultant’s undertaking,
      Consultant shall be paid four (4) million shares of the Company’s common stock
      no later than June 30, 2004, and a monthly stipend as may be mutually agreed
      upon.

    Consultant
      shall provide the services to the Company as set forth hereinabove as an
      independent contractor.

    2.         
      Non-Competition
      and Confidentiality:

    (a)         
      Consultant
      covenants and agrees that neither it nor its employees will, during the term
      of
      this Agreement, and for a period three (3) years thereafter, except with the
      express prior written consent of the Company, directly or indirectly, whether
      as
      employee, owner, partner, director or officer, for its own account or for the
      benefit of any person in a business in competition with the Company or
      producing, distributing or marketing a product the same as or similar to a
      product either existing or in the development phase of the Company.

    (1)         
      Solicit,
      divert or otherwise take away or interfere with any client of the Company,
      including all clients directly or indirectly produced or generated by
      Consultant.

    (2)         
      Solicit,
      divert or induce any of the Company’s employees to leave the Company or to work
      for Consultant or any person with whom Consultant is connected.

    (b)         
      If
      any
      portion of the covenants or agreements contained herein, or the application
      thereof, is construed to be invalid or unenforceable, then the other portions
      of
      such covenant(s) or agreement(s) or the application thereof shall not be
      affected and shall be given full 

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

    force
      and
      effect without regard to the invalid or unenforceable portions. If any covenant
      or agreement herein is held to be unenforceable because of the area covered,
      the
      duration thereof, or the scope thereof, then the court making such determination
      shall have the power to reduce the area and/or duration and/or limit the scope
      thereof, and the covenant or agreement shall then be enforceable in its reduced
      form.

    (c)         
      Consultant
      acknowledges that its services to the Company will enable it to obtain
      confidential information concerning the Company, its affiliates, if any, and
      information about the trade secrets of the Company and its employees, including
      but not limited to, the following: customer lists; provider lists; marketing
      and
      new product development plans; work in progress by the Company, whether or
      not
      developed; operational methods and other business affairs and methods, including
      plans for future developments, not known or available to the general public
      (collectively the “Confidential Information”). Consultant further acknowledges
      that the services to be performed under this Agreement are of a special, unique,
      unusual and extraordinary character, and that the expertise, reputation and
      standing of Consultant will be developed and enhanced as a result of the
      opportunities afforded to Consultant by reasons of its employment by the
      Company. Accordingly, Consultant agrees that it shall not, during or subsequent
      to the term of this Agreement, knowingly reveal, divulge or make known to any
      person (other than the Company or any affiliate of the Company) any of the
      Confidential Information.

    The
      Consultant shall not use for itself or disclose to others, directly or
      indirectly, except to its employees on a “need-to-know” basis, any Confidential
      Information and shall retain any and all Confidential Information acquired
      or
      developed by it during the Service Period in the strictest of confidence and
      in
      trust for the sole benefit of the Company, its affiliates, if any, and their
      successors 

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

    and
      assigns and shall deliver promptly to the Company upon expiration or termination
      of this Agreement, or at any other time the Company requests, all memoranda,
      notes, records, reports and other documents (and all copies thereof) relating
      to
      the business of the Company, or its customers which Consultant obtained while
      employed by, or otherwise serving or acting on behalf of the Company and which
      the Consultant may then possess or have under his control.

    For
      purposes of this Agreement, in addition to the items referred to above as being
      “Confidential Information,” any document designated by the Company as being
“Confidential” shall be automatically deemed to be so, and said election by the
      Company shall be deemed binding, final and conclusive upon Consultant.

    The
      provisions of this Article 2 shall survive the termination or expiration of
      this
      Agreement.

    5.         
      Miscellaneous:

    (a)         
      Indulgences.
      Neither
      the failure nor any delay on the part of either party to exercise any right,
      remedy, power or privilege under this Agreement shall operate as a waiver
      thereof, nor shall any single or partial exercise of any right, remedy, power
      or
      privilege with respect to any occurrence by construed as a waiver of such right,
      remedy, power or privilege with respect to any other occurrence.

    (b)         
      Controlling
      Law.
      This
      Agreement and all questions relating to its validity, interpretation,
      performance and enforcement shall be governed by and construed in accordance
      with the laws of the State of Florida, other than conflicting choice-of-law
      provisions.

    

    

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

    

    (c) Notices.
      All
      notices, requests, demands and other communications required or permitted under
      this Agreement and the transactions contemplated herein, shall be in writing
      and
      shall be deemed to have been duly given, made and received when delivered
      against receipt, or when sent by United States Postal Service registered mail,
      return receipt requested, postage prepaid, addressed as set forth
      below: 

    

    (1) If
      to the
      Company or its Board of Directors:

     

    EYE
      CARE
      INTERNATIONAL, INC.

    1511
      N.
      Westshore Blvd., Suite 925

    Tampa,
      Florida 33607

    

    Attention:
      The CEO

    

    
      	(2)  	
              If
                to the Consultant:

            

    

     

    Jana
      Corporation

    770
      SE
      19th
      Ave.,
      Suite 1

    Deerfield
      Beach, FL 33441

    

    Attention:
      Steven Kaye

    

    Any
      party
      may change the address to which communications or copies are to be sent by
      giving notice of such change of address in conformity with the provisions of
      this paragraph for the giving of notice.

    (d)         
      Earlier
      Termination
      Either
      party may terminate this Agreement, with or without cause, at any time, by
      giving the other party thirty days written notice of such termination, the
      termination date being thirty days following receipt of such notice. The
      provisions of Paragraph 2 above shall survive termination of this Agreement
      for
      any reason.

    
      
        
        

      

      
        5

        
          

        

      

      
        
        

      

    

    

    (e)         
      Binding
      Nature of Agreement.
      This
      Agreement shall be binding upon and inure to the benefit of the Company and
      it
      successors and assigns, and shall be binding upon Consultant and its successors
      in interest.

    (f)         
      Provisions
      Separable.
      The
      provisions of this Agreement are independent of and separable from each other,
      and no provisions shall be affected nor rendered invalid or unenforceable by
      virtue of the fact that for any reason any other or others of them may be
      invalid or unenforceable, in whole or in part.

    (g)         
      Paragraph
      Headings.
      The
      paragraph headings in this Agreement are for convenience only, and they form
      no
      part of this Agreement and shall not affect its interpretation.

    (h)         
      Assignment.
      This
      Agreement shall be deemed fully assignable by the Company.

    (i)         
      Each
      party hereto acknowledges receipt of an executed copy of this
      Agreement.

    IN
      WITNESS WHEREOF,
      the
      parties hereto have caused this Agreement to be executed and delivered as of
      the
      date first above written.

    The
      foregoing Agreement is subject to the approval of the Company’s Board of
      Directors.

    

    
      	
              JANA
                CORPORATION

            	
              EYE
                CARE INTERNATIONAL, INC.
                

            
	 	 
	 	 
	 	 
	
              By:
                __________________________________

            	
              By:
                ________________________________

            
	
                    
                Steven Kaye 

            	
                    
                Clark A. Marcus, President and CEO

            

    

    
 

     

     

     

     

    6<PAGE>

                                            [SPENCER TRASK SPECIALTY GROUP, LLC]

                            11.5% SENIOR SECURED NOTE

$250,000  U.S.
New York, New York                                                  May 27, 2005

1.      DEFINITIONS. For purposes of this Note:

        A.      BORROWER. The "Borrower" means Vyteris Holdings (Nevada), Inc.,
a Nevada corporation having its chief executive office at 13-01 Pollitt Drive,
Fair Lawn, New Jersey 07410.

        B.      COLLATERAL. "Collateral" means any collateral, subordination,
guaranty, endorsement or other security or assurance of payment, whether now
existing or hereafter arising or accruing, that now or hereafter secures the
payment of or is otherwise applicable to the Outstanding Principal Account or
any interest or other amount payable pursuant to this Note and remaining unpaid.

        C.      EVENT OF DEFAULT. "Event of Default" has the meaning set forth
in SECTION 6 hereof.

        D.      INTEREST. "Interest" has the meaning set forth in SECTION 3
hereof.

        E.      LENDER. The "Lender" means Spencer Trask Specialty Group, LLC, a
New York limited liability company, having its chief executive office at 535
Madison Avenue, New York, New York 10022.

        F.      MATURITY DATE. The "Maturity Date" shall be July 27, 2005.

        G.      NOTES. This Note is part of a series of 11.5% Senior Secured
Promissory Notes of like tenor issued on the date hereof on identical terms, in
an aggregate principal amount equal to up to $2 million, and are collectively
referred to as the "Notes."

        H.      OUTSTANDING BALANCE. The "Outstanding Balance" means the sum of
the outstanding Principal Amount and any Interest accrued hereunder from time to
time.

        I.      PRINCIPAL AMOUNT. The "Principal Amount" means the outstanding
principal amount of this Note from time to time.

        J.      TRANSACTION DOCUMENTS. The "Transaction Documents" shall mean
this Note, and any other notes issued in connection with the Loan, and the
Security Agreement as defined in SECTION 7 hereof.

2.      PROMISE TO PAY. The principal amount plus all accrued and unpaid
interest owing under this Note shall be paid on the Maturity Date.

<PAGE>

3.      INTEREST. Interest, calculated on the basis of a 365-day year for the
actual calendar days elapsed (365 or 366, as applicable), on the Principal
Amount from and including the date of this Note to but not including the date
the Outstanding Balance is paid in full at a rate per year that shall on each
day be 11.5% (the "Interest").

        The Outstanding Balance as of the Maturity Date shall automatically
become due and payable on the Maturity Date.

4.      PAYMENTS WITHOUT PREMIUM OR PENALTY. The Borrower shall have the option
before the Maturity Date or upon the occurrence of an Event of Default of paying
the Outstanding Balance to the Lender in full or part at any time and from time
to time without any premium or penalty.

5.      AMOUNTS IMMEDIATELY DUE. The Outstanding Balance and other amounts
payable pursuant to this Note and remaining unpaid shall, without any notice,
demand, presentment or protest of any kind (each of which is knowingly,
voluntarily, intentionally and irrevocably waived by the Borrower),
automatically become immediately due upon the occurrence of any Event of
Default.

6.      EVENTS OF DEFAULT. If any one or more of the following events (each, an
"Event of Default") shall occur, that is to say:

        A.      The Borrower shall fail to make any payment in respect of
Interest (including additional interest) on or principal of this Note within
five (5) days of becoming due, whether at maturity or by acceleration or
otherwise; or

        B.      Any default or event of default shall occur with respect to any
other indebtedness of the Borrower exceeding $100,000 which results in any
payment with respect to such indebtedness for borrowed money becoming due prior
to its stated maturity; or

        C.      A final judgment which, in the aggregate with other outstanding
final judgments against the Borrower, exceeds $100,000 shall be rendered against
the Borrower and, if within 45 days after entry thereof, such judgment shall not
have been discharged or stayed pending appeal, or within 45 days after
expiration of such stay such judgment shall not have been discharged; or

        D.      The Borrower shall:

                (i)     commence a voluntary case under Title 11 of the United
States Code as from time to time in effect, or authorize, by appropriate
proceedings of its board of directors, the commencement of such a voluntary
case;

                (ii)    have filed against it a petition commencing an
involuntary case under said Title 11 which is not dismissed or vacated within 90
days after the date the same is filed;

                (iii)   seek relief as a debtor under any applicable law, other
than said Title 11, of any jurisdiction relating to the liquidation or
reorganization of debtors or to the modification or alteration of the rights of
creditors, or consent to or acquiesce in such relief;

                                    -- 2 --
<PAGE>

                (iv)    have entered against it any order by a court of
competent jurisdiction (i) finding it to be bankrupt or insolvent, (ii) ordering
or approving its liquidation, reorganization or any modification or alteration
of the rights of its creditors, or (iii) assuming custody of, or appointing a
receiver or other custodian for, all or a substantial part of its property and,
in the case of clause (ii) or (iii), any such order shall not have been vacated
or rescinded within 90 days after the date such order was entered; or

                (v)     make an assignment for the benefit of, or enter into a
composition with, its creditors, or appoint or consent to the appointment of a
receiver or other custodian for all or a substantial part of its property; or

then, and in each and every case, the Lender may declare the Outstanding Balance
of this Note to be immediately due and payable, and thereupon the Outstanding
Balance shall become so due and payable without presentation, presentment,
protest or further demand or notice of any kind, all of which are hereby
expressly waived, and the Lender may proceed to enforce payment of such amount
in such manner as it may elect.

7.      SENIOR SECURED RIGHTS TO COLLATERAL. This Note shall be secured by that
certain Security Agreement (the "Security Agreement") by and among the Lender
and Vyteris, Inc., a wholly-owned subsidiary of the Borrower, dated of even date
herewith, as may be amended from time to time.

        The indebtedness evidenced by the Notes and the payment of the
Outstanding Balance of each of the Notes shall be Senior (as hereinafter
defined) to, and have priority in right of payment over, all indebtedness of
Borrower for borrowed money, outstanding as of the date hereof or hereinafter
incurred, other than purchase money equipment financing. "Senior" as used herein
shall be deemed to mean that, in the event of any default in the payment of the
obligations represented by the Notes (after giving effect to "cure" provisions,
if any) or of any liquidation, insolvency, bankruptcy, reorganization, or
similar proceedings relating to the Company, all sums payable on Notes shall
first be paid in full, with interest, if any, before any payment is made upon
any other indebtedness for borrowed money, other than purchase money equipment
financing, now outstanding or hereinafter incurred, and, in any such event, any
payment or distribution of any character which shall be made in respect of any
other indebtedness of the Company shall be paid over to the Lender of this Note
for application to the payment hereof, unless and until the obligations under
this Note (which shall mean the principal and other obligations arising out of,
premium, if any, interest on, and any costs and expenses payable under, this
Note) shall have been paid and satisfied in full.

8.      NO OTHER SENIOR INTERESTS. Except for (i) the rights of Becton,
Dickinson and Company ("Becton") to receive certain royalties in respect of
certain products developed using certain intellectual property rights
transferred by Becton pursuant to Section 8.05 of that certain Transaction
Agreement, by and between Becton, Spencer Trask Specialty Group, LLC, Spencer
Trask Ventures, Inc. and the Vyteris, Inc., dated November 10, 2000, (ii) the
rights of B. Braun Medical Inc. to certain distribution and license rights to
use the Borrower's Trademarks, Patents (each as defined in the Security
Agreement) and related intellectual property rights pertaining to the Borrower's
transdermal lidocaine delivery system pursuant to Section 2 of that certain
License, Development and Distribution Agreement, dated September 20, 2002, (iii)
purchase

                                    -- 3 --
<PAGE>

money liens against equipment, and (iv) the holders of the other Notes issued in
connection herewith, the Borrower owns each of the General Assets, Trademarks,
Patents and Licenses (each as defined in the Security Agreement) free and clear
of any and all liens, claims or security or adverse interests to all or any of
the Trademarks, Patents and Licenses free and clear of any and all liens, claims
or security or adverse interests to all or any of the Trademarks, Patents and
Licenses on file or of record in any public office, except as such as have been
filed in favor of the Lender pursuant to this Agreement.

9.      COVENANTS. Except with respect to the other Notes, the Borrower hereby
covenants and agrees, so long as any Outstanding Balance remains payable
pursuant to this Note:

        A.      It will not grant or attempt to grant any person or entity a
security interest in the Collateral or any portion thereof senior to, with
priority over, or PARI PASSU with the security interest granted to the Lender
pursuant to the Security Agreement.

        B.      It will not pledge or attempt to pledge the Collateral or any
portion thereof to any person or entity.

10.     GOVERNING LAW. This Note shall be governed by and construed, interpreted
and enforced in accordance with the law of the State of New Jersey and the
federal law of the United States without regard to the law of any other
jurisdiction.

11.     WAIVER OF TRIAL BY JURY AND CLAIMS TO CERTAIN DAMAGES. THE BORROWER
KNOWINGLY, VOLUNTARILY, INTENTIONALLY AND IRREVOCABLY WAIVES EACH RIGHT THE
BORROWER MAY HAVE TO A TRIAL BY JURY WITH RESPECT TO, AND EACH RIGHT TO ASSERT
ANY CLAIM FOR DAMAGES (INCLUDING, BUT NOT LIMITED TO, PUNITIVE DAMAGES) IN
ADDITION TO ACTUAL DAMAGES IN, ANY ACTION OR OTHER LEGAL PROCEEDING, WHETHER
BASED ON ANY CONTRACT OR NEGLIGENT, INTENTIONAL OR OTHER TORT OR OTHERWISE,
ARISING OUT OF OR OTHERWISE RELATING TO (A) THE LOAN OR COLLATERAL, THIS NOTE OR
ANY OTHER WRITING HERETOFORE OR HEREAFTER EXECUTED IN CONNECTION WITH THE LOAN
OR COLLATERAL, (B) ANY TRANSACTION ARISING OUT OF OR OTHERWISE RELATING TO THE
LOAN OR COLLATERAL, THIS NOTE OR ANY SUCH OTHER WRITING OR (C) ANY NEGOTIATION,
ADMINISTRATION, PERFORMANCE OR ENFORCEMENT OF THE LOAN OR COLLATERAL, THIS NOTE
OR ANY SUCH OTHER WRITING.

                                    -- 4 --
<PAGE>

12.     CONVERSION; WARRANTS.

        A.      Unless the entire Outstanding Balance hereunder has been repaid
in full by the Company to the Lender on or before the Maturity Date, on the
Maturity Date the Company and the Lender shall cause this Note to be converted
into the an 11.5% Senior Secured Grid Note pursuant to that certain Securities
Purchase Agreement, dated as of September 28, 2004, by and between Lender and
the Company (the "SPA").

        B.      On the date hereof, the Company has issued to the Lender
warrants in the form attached hereto as EXHIBIT A.

                                VYTERIS HOLDINGS (NEVADA), INC.

                                By: /s/ Vincent DeCaprio
                                    --------------------
                                    Name: Vincent DeCaprio, Ph.D.
                                    Title: President and Chief Executive Officer

                                    -- 5 --
<PAGE>

                                    EXHIBIT A
                                 FORM OF WARRANT

                                    -- 6 --

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00089-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00089-of-00352.parquet"}]]